Pathstone Holdings’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$486K Sell
12,051
-4,737
-28% -$177K ﹤0.01% 1765
2025
Q4
$584K Sell
16,788
-1,225
-7% -$96.2K ﹤0.01% 1683
2025
Q3
$1.5M Buy
18,013
+144
+0.8% +$10.4K 0.01% 1184
2025
Q2
$1.31M Sell
17,869
-1,296
-7% -$94K 0.01% 1248
2025
Q1
$2.19M Buy
19,165
+5,951
+45% +$362K 0.01% 929
2024
Q4
$666K Sell
13,214
-220
-2% -$11.5K ﹤0.01% 1596
2024
Q3
$622K Buy
13,434
+609
+5% +$21.6K ﹤0.01% 1627
2024
Q2
$417K Buy
12,825
+3,331
+35% +$91.2K ﹤0.01% 1790
2024
Q1
$239K Sell
9,494
-7,974
-46% -$188K ﹤0.01% 2054
2023
Q4
$567K Buy
+17,468
New +$480K ﹤0.01% 1425

Other funds holding CORT